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Summary 
 
The research program proposal, CRP4, as the title implies, addresses the strategic system level objective 
in the CGIAR Strategic Research Framework; “to improve nutrition and health”. As the only CRP to 
address health and nutrition explicitly, it should add considerable value to the CRP portfolio, given 
mounting evidence that food supply and access to food are not enough to achieve favorable nutritional 
outcomes. Selection of the four main research themes (Value chains for enhanced nutrition; 
Biofortification; Prevention and control of agriculture-associated diseases (AAD); and, Integrated 
Animal, Health and Nutrition (AHN) programs and policies) provides a generally logical approach to the 
subject matter for the CGIAR. It incorporates and builds on the Harvest Plus and Agrosalud programs and 
other existing activities1.  Innovative features of the proposed research programs include searching for 
solutions to poor health and nutrition beyond just producing more food, through value chain approaches 
and by targeting specific demand side outcomes through influencing poor consumers’ behavior. 
  
The proposal is generally outcome-focused and the desired impacts are relevant, although few provide 
quantified information or a time frame for their achievement.  Gender issues are given appropriate 
attention, supported by a strong justification of their importance. Simplified CRP impact pathways are 
described (Figure 2) with three clear entry points; value chains, development program implementation 
and policy. The IPG elements, however, are not well developed, and some of the work appears very local 
in nature. But much of the research could have strong IPG elements if efforts are made to do so. Some of 
the components provide a 10 year perspective but the proposal notes (p119; Table 19, p120) that a three 
year period is required to turn the current aggregation of subjects into a prioritized workplan.  This is 
needed to be confident of the program’s future utility as, currently, the scope of the activities sketched 
under general headings would seem to be too broad. That so many “tools and approaches” are to be 
defined or validated as a first step in the research, and that “characterization” and “assessment” of 
problems still needs to be done, is a cause for concern. The ISPC expected a stronger understanding of the 
problems and the potential solutions as the foundation for this proposal.  After many decades of 
discussion about the links between agriculture and nutrition it is disconcerting to read that much of the 
research proposed would be to improve understanding rather than generate evidence of effective 
solutions. 
 
Overall, the proposed research should be prioritized. The current balance between the different 
components can be questioned and in two research components (1 and 3) the ISPC believes the Program 
                                                 
1
 In many ways the current proposal is the former CGIAR Agriculture and Health Research Platform writ large. It would be 
preferable in the redevelopment of the CRP4 proposal to utilize the same short and accurate statements about the objectives of 
each component (see http://programs.ifpri.org/ahrp/ahrpabout.asp) which provide a much clearer description of the true extent of 
CGIAR experience and capacities in the several fields. 
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seeks to do too much and hence is likely to lose its focus on delivery.  In these cases, prioritization is 
needed and trade-offs in pursuing alternative research choices should be provided.  
  
Given the lack of detail, the quality of the science has to be largely assumed based on the track record of 
the Centers involved. Confidence about the quality would be enhanced, however, if more reference was 
made to the underlying hypotheses which will be required to develop research plans. The Program has a 
wide variety of partners although, for some components, the involvement with ARIs remains to be 
defined.  Fuller consultation with other key agencies is promised and is a prerequisite before new 
priorities can be developed or refined, particularly for the newer research components (1, 3 and 4). It will 
be incumbent on the program’s proponents to narrow the aspirational agenda of activities and find the 
program’s proper place in relation to global networks of research and development players (which the 
proposal lists) with active expertise in the nutrition and health fields.   
 
The linkages to other CRPs are listed but it is often not easy to interpret exactly in which CRP the 
research will take place. This raises questions of boundaries and “co-financing”, which was also a 
concern with the climate change proposal.   
 
The ISPC has commented previously, in relation to CRP 3.7 (Meat, milk and fish) that relationships 
between basic technological research on livestock disease and the more immediate research needs that 
may be selected through constraint analysis of the chosen livestock and fish value chains, requires better 
analysis and description. In the current proposal, links are made (p71) between sub-component 1 (Food 
Safety) of Component 3 and the value chain work in CRP 3.7, but in sub-component 2 (Zoonoses), 
despite a long rationale for treating zoonotic disease in general, no explanation is proposed for the two 
diseases singled out (p79).  Given that cysticercosis is a food-borne disease, it is difficult to see the 
overall strategy as to how synergies both within and between CRPs will be captured. The ISPC would 
welcome clarification of how the different sub-components across CRPs in this area fit together.  
 
Overall, the document provides a good description of the “why” although, despite its lengthy text, the 
proposal is unclear or lacks details in several instances on the “how”. This makes it difficult to apply the 
CRP evaluation criteria to judge the likelihood of delivery of high quality science and the intended 
impacts. The time frame for many of the deliverables is left quite open. Thus it does not make sense 
(contrary to the suggestion of the proposal, p128), to embark on a rapid deployment of CRP4 in 2011 
before many of the major potential partners have been adequately consulted to refine activities and a more 
structured and balanced work plan is in place. 
   
Recommendation: Because the current proposal is not sufficiently developed, the ISPC recommends that 
the CRP 4 approach be approved to allow the program’s proponents to engage with partners so as to 
develop a revised proposal and work plan with greater specificity. Whilst current work, including the 
experimental validation of biofortification, should continue as planned, the ISPC further recommends that 
approval of the remaining content and substance of the program be withheld until a more detailed 
proposal is submitted. That proposal should take into account the general and more detailed advice 
contained in this Commentary: 
 
• The articulation of the strategy in the revised proposal should give evidence that the problems 
identified are recognized by the authorities in countries with major under-nutrition problems and 
a clearer specification of objectives related to the target groups affected by agricultural 
intensification should be provided. 
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• Many of the research activities are described at a high/generic level and some are already 
underway or have been completed by partners. The revised proposal should identify the research 
activities with time-bound milestones and partner roles.  
• On the basis of more detailed activities and specified outputs the revised proposal should include 
a strategy for how these will be utilized to maximize the IPG benefits and the impacts on/for the 
specific communities identified. 
• In some parts (components 1 and 3 in particular) the proposals are aspirational rather than 
realistic and this should be addressed through further prioritization during the process of strategy 
development.  
• The proposal should make clearer use of nutrition and health–related terminology and articulate 
the researchable hypotheses underlying the major areas of research to be included as well as 
providing a mechanism or evidence for the quality of science underpinning each approach.   
• Further detail on linkages to other CRPs should be described, in particular making clear which 
work will be funded from which CRP. 
• The ISPC encourages a strategic approach to program evolution and the avoidance of 
opportunistic inclusion of some activities simply because they may draw initial funding.  
 
1. Strategic coherence and clarity of Program objectives 
 
The overall objective and four research components of CRP4 directly address the System Level Outcome 
(SLO) of improvement of health and nutrition. In developing this proposal, four areas emerged from a 
brainstorming session of 12 CGIAR Centers. As a result, the underlying logic and potential scientific 
synergies which can be achieved by achieving focus of these Centers on AHN are apparent. However, it 
would be more convincing if these were ‘ground-truthed’ against the priorities of the 36 highest 
nutritionally burdened countries (based on stunting). Before embarking on strengthening such stakeholder 
interactions, however, it may be useful to better define the ‘problem’ of under-nutrition. Nutrition is not 
one status, process or situation (nor is health). The nearly interchangeable use of terms like food security, 
hunger, malnutrition, under-nutrition, ill health, and poverty throughout the proposal did not help provide 
clarity. Drilling down to what aspects of nutrition and health problems would be best tackled through 
investments in agriculture should be a research question in itself. The risk is that the focus on integrating 
agriculture, nutrition and health over time becomes a mantra which dominates over the focus on 
outcomes. As written, it is the food chain rather than simply agriculture which is the subject of study. 
 
That said, the program seeks to address several of the main causes of malnutrition and agriculture-
associated diseases (AAD) and to identify possible avenues for improvement. The questions leading to 
this identification of the research components (p 9) are the appropriate ones. However, the balance 
between the individual research components, with more than fifty percent of the resources going to one 
component (biofortification) invites review.  A stronger justification is required for this apparent 
imbalance in the allocation of resources. The proposal seems to suggest that Harvest Plus and AgroSalud 
will be stand-alone elements of the new program, and the degree to which they may subsequently be 
merged  (with other components) into a future sub-component on biofortification is unclear.  An overall 
conceptual framework to provide a cohesive articulation of the Program is missing.  
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The program targets two groups: (a) those with high level of malnutrition and AAD’s and (b) groups 
affected by agricultural intensification (see for example p ix).  While the profile of the first group is well 
understood, the characteristics and objectives for the second are not clear.  For example, the foreword (p 
ix) mentions the “poor people” in this group, whereas the text (p11) mentions all groups. Is there a clearly 
proven link between intensification and greater health and nutritional risks for the poor? What is the 
program’s objective for this group?  If it is to provide safer food, the ISPC would argue that the program 
would seek to cover all groups, including planning for the inclusion of the urban poor in the future, and 
not only the rural poor. Lastly, in considering targets, one of the challenges to the value chain work is that 
many value chains serve both undernourished and over nourished people, so that entry points via value 
chains may be a very blunt instrument. 
 
The international public goods nature of the research is obvious in the bio-fortification component (and 
should be for zoonoses when this is more clearly developed), but less clear in the other components.  
Working on value chains, food safety and policies and institutions will result in local solutions.  The 
program has addressed the issue of generating international public goods by including the development of 
methodologies and tools, but this aspect needs to be more explicitly stressed in a revised proposal.   
 
Component 1 on Value chains. Overall this seems a sensible choice but the extent to which research can 
push changes in value chains to meet the numerous objectives of efficiency, sustainability, and now 
nutrition, should be subject to tradeoff analysis. For objective 4 (identifying the nutrition entry points for 
intervention), which is clearly the most significant activity in this component, the selection criteria should 
include a poverty focus to respond to the CGIAR’s comparative advantage for being involved in this 
work. In addition, this component will require close interaction with the private sector to be effective but 
the CGIAR partners have to date little experience in developing tools for “chain agents” to assess and 
enhance nutrients in foods. There is a lack of reference to policy incentives and distortions as a potentially 
important determinant of nutritional outcomes of value chains, for example subsidies on specific 
products.  
 
A significant element seems to focus on changing consumer behavior, which is a very challenging area 
with little clarity about likelihood of success. It is very difficult to change consumer behavior, even in rich 
countries, and even with so much media attention on healthy foods and diet improvement. Research in 
this area will need to go well beyond economics to embrace consumer psychology, an area in which the 
CGIAR is weak. The feasibility of success in this area is rated by the ISPC as “optimistic”. Evidence of 
strong buy-in from stakeholders who are in a position to influence consumers would be critical here. 
 
Component 2. Biofortification. The Harvest Plus CP appears to continue unchanged as a component of 
this CRP. Some protection may well be needed to ensure that the work started in this CP is given a chance 
to succeed, but it currently appears isolated. Indeed, it is considered an important feasibility experiment 
which may well temper future strategies and investment in this area. AgroSalud will work with food 
technologists to produce commercially prepared biofortified food resulting in urban consumers having 
access to biofortified food (p54/p57). This is one of the few examples of engagement with the nutrition 
and health of urban consumers in the proposal. Indeed, rapid urbanization underway in many developing 
countries is associated with a major change in diets such that a growing share of food consumed by urban 
poor is processed.  Achieving impact on nutrition for this group may well require greater collaboration 
with the food processing and manufacturing industries. This will represent new partners and, as 
mentioned, may require further definition of target groups. 
 
Component 3. Agriculture Associated Diseases. The text in this component is repetitive and hard to 
follow as it seems to have a different structure and format from the other components. Research on 
zoonotic and food/water-borne diseases is urgently needed but what the CGIAR should contribute is less 
well articulated.  The description on p79 is extremely broad. In component 3, there is reference to One 
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Health as an overarching approach, but no specific actions on understanding and eventually overcoming 
the constraints to its implementation. With attention of many institutions, including the major 
development banks and other investors on this subject, the comparative advantage of the CGIAR in this 
topic needs to be clear. For instance, specific work on the constraints and benefits of the introduction of 
“One Health” would have to be a part of this program. However, it could equally well be argued that this 
activity belongs in component 4.  
 
The attention to mycotoxins (given “initial priority” status) is supported, and the ISPC notes there are a 
large number of potential partners. The System-wide IPM program is mentioned as a partner for aflatoxin 
research without identifying what role it might play (p68). In contrast, the System-wide IPM program is 
not mentioned in tackling research questions associated with reducing pesticide use and effects on 
ecosystems (p82), which is one of the major health risks from agriculture as measured by DALYs.  
 
Otherwise too much emphasis is given in the background text to acute food safety issues (pandemics) 
which are the responsibility and expertise of the OIE, FAO and WHO and their networks, when research 
on other more long-standing constraints could be the focus of the proposed research for the CGIAR.   
In the current proposal, one sub-component focuses on zoonoses, but there is overlap with the sub-
component on food safety. It is not clear how much effort will be directed at the selected zoonoses (Rift 
Valley Fever and cysticercosis) referred to on p79, but the rationale for their selection is missing. Further 
clarity is required on the zoonotic diseases to be prioritized under this proposal and the relationship 
between these thrusts and underpinning strategic work on livestock disease promised under CRP 3.7. 
  
Within component 3 there are indications that concepts from economics will be used in a behavioral 
setting in disease control. This is extremely important, and a welcome emphasis wherever the research is 
placed. Diseases may originate in animals, but decisions on disease control are made by humans, and 
unless an effort is made to understand the incentive structures facing livestock keepers and other 
stakeholders in a disease control situation, technical disease control is likely to be ineffective. That said, 
the description of socio-economic data collection and impact assessment is sketchy, especially in 
comparison to the other three components. For instance, Table 11 (p74) has proper descriptions of 
technical disease control research activities, but just a simple bullet point noting ‘health, social and other 
impact assessments’.  
 
Component 4. Cross sectoral. Focusing subcomponent 4.1 (on integrating ANH programs) could provide 
early understanding (for the program) of how best to create an integrated program. However, written as a 
stand-alone component, it comes across as verging on the theoretical; ‘Develop methods and tools to 
improve the effectiveness, efficiency, and timeliness of surveillance and monitoring systems and to 
permit meaningful evaluation of complex multisectoral programs and policies (Components 1-4)’ could 
rightly be seen as an objective within components 1-3. More could be done at this stage to demonstrate 
how the key activities of 4.1 will influence and add value to activities in the first 3 components and not 
just provide an ex post service to other donor initiatives. Such evaluations should pay special attention to 
prospects for scaling up. Some of the case studies may provide favorable nutritional impacts but have 
little chance of success at larger scale. 
 
2. Delivery focus and plausibility of impact 
 
In the sense that the ultimate impact statements are appropriate, the proposal could be seen as outcome 
focused. Considerations with respect to delivery are discussed throughout the proposal and the way in 
which partners have been selected shows evidence of thinking about delivering impact. There is also a 
clear geographic focus. However, at this stage of development, the many assertions about the program’s 
potential for impact on nutritional status and health are vague and unconvincing. Generic claims that the 
‘health and nutrition of the poor and undernourished will be improved’ are not good enough given the 
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scale of funding requested. Only the Harvest Plus activities attempt to define which nutrients and 
quantitative nutritional metrics, and for which target demographics, the work is intended. The proposal as 
a whole may need to discuss its measures of success with some care. Will a 5% decline in iron deficiency 
anemia in children under 5 suffice to determine success, or is it a 20% decline in stunting? Is health really 
just a reduced exposure to, say, schistosomiasis or should it be a 50% reduced prevalence of diarrhoeal 
disease (which kills far more children than schistosomiasis does)?  
 
Target groups are not well defined or the wording is unclear. The program targets two groups (a) groups 
with high level of malnutrition and AADs, and, (b) groups affected by agricultural intensification (see for 
example page ix).  While the profile of the first group is well understood, the characteristics and 
objectives for the second are not clear.  For example, the foreword (pix) mentions the “poor people” in 
this group, whereas the text (p11) mentions all groups.  What is the program’s objective for this group?  Is 
there a clearly proven link between agricultural intensification and greater health and nutritional risks for 
the poor? A closely connected choice expressed in the proposal is the focus on poor rural and peri-urban 
populations. In the next 20 years, developing countries in both Africa and Asia are set to join Latin 
America in having over half their populations resident in urban areas. The disconnect between production 
and consumption is going to get steadily larger, nutrition of poor urban populations is going to become 
ever more important, processed food is going to become more central in diets and value chains are going 
to become more complex and spatially dispersed. It may make sense to prepare the groundwork for 
eventual inclusion of urban groups in the proposal. 
 
Page 1 notes that the “primary focus will be on improving human nutrition and health”. That requires a 
significant allocation of resources to demonstrate that investments in (mainly) agricultural research will 
indeed result in improved nutrition and health, not just in nutritionally-enhanced foods, or in a reduction 
of agriculture-based diseases. The absence of disease does not in itself equate with improved health, nor 
does increased availability of more nutritious foods equate with enhanced nutritional status of consumers 
(given potential anti-nutrients in the diet, nutrient losses in processing/cooking or via communicable 
diseases, or lack of needed investments in nutrition and health promotion separate from investments in 
agriculture). Thus the pathways are a) not as clearly defined as suggested in the text, and b) the impacts 
are likely to be more muted than claimed. Indeed, plausibility of impact can only be assessed in relation to 
stated objectives but the quantification of these objectives is not well defined in the text (Harvest Plus 
excepted). There is some discussion and attention to trade-offs - for example between bio-fortification 
and yield (p43), but the pros and cons of other choices are not discussed in detail.  For example, on food 
safety, ILRI’s Kenyan raw milk sale case study (p60) is mentioned, but the critical strategic issue that 
stricter food safety standards increase the cost of foodstuffs, and hence affect their accessibility to the 
poor, is not discussed. 
   
That so many ‘tools and approaches’ are to be defined or validated as a first step in the research, and that 
“characterization” and “assessment” of problems still needs to be done, is a cause for concern. The ISPC 
expected a stronger understanding of the problems and the potential solutions as the foundation for this 
proposal.  After many decades of discussion about the links between agriculture and nutrition it is 
disconcerting to read that much of the research proposed would be to improve understanding rather than 
generate evidence of effective solutions. With so much vagueness around the actual hypotheses to be 
tested and actual interventions to be evaluated, the impact of CRP4 cannot be easily predicted. The 
program potentially includes some innovative social sciences; but to have the intended impacts the 
proposal will have to achieve and integrate both social and biotechnical outputs (e.g. p79; “Surveillance 
and control options based on improved understanding of disease; diagnostics that take into account 
variants in circulation” etc).  Simple, illustrative impact pathways are provided for the components 
reflecting the actors, but lack a good description of the levers (positive or negative incentives, awareness, 
lobbying mechanisms) needed to get the Program findings internalized in the chain. Overall, the research 
is a mixed bag of plausible and feasible, difficult to achieve, and unclear (particularly in terms of defining 
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the precise impact pathways expected). That the CRP proposes to adopt SMART indicators and methods 
to determine impacts is good, and that will require a clear investment in collecting appropriate nutrition 
and health variables to assess impact and partner involvement.  
 
Finally, in terms of program plausibility, the ISPC would also draw attention to some of the statements 
made, e.g. p9: “It is well recognized that poor quality diets and related micronutrient deficiencies are a 
much more widespread nutritional problem than the lack of food. Solutions to improving the poor’s 
access to nutritious foods are therefore needed, rather than a narrow focus on producing more food.”  It is 
incumbent on the proponents to show that impact on this issue can also be anticipated through this new 
direction for research in the CGIAR. 
 
3. Quality of science 
 
The program has no clearly formulated hypotheses relating to the needs and constraints identified. It has 
formulated an objective for each component - which is generally well done, with the exception of the 
overall program objective - and a large number of research questions. The questions are relevant and are 
mostly addressed in the subsequent research program.  However, these questions do not allow a rigorous 
validation or rejection. 
  
The program seems, in particular in component 1 and 3, quite ambitious in the number of proposed 
activities as shown in table 4 and 10. Leaner, more focused research activities in these components might 
enhance their scientific quality. 
  
A more explicit description of new techniques and tools used and novel outcomes expected in each 
research component would have given a better understanding of the innovative character of this CRP.    
Component 1 makes good use of case studies to develop the research issues (e.g. Box 2, providing 
support for the potential to enhance and increase bioavailability of Vitamin A in staples). Research 
component 1, objective 2, proposes to employ innovative techniques, whereas the rest is quite traditional; 
research component 2 is innovative overall. Component 3 starts by describing research themes at the 
component level, one of which aims to identify AADs with large impact on health of the poor, yet some 
diseases have already been prioritized. Quite a few stakeholders already work in the area of zoonosis, 
which raises questions about the extent to which the CGIAR should be leading in this area as opposed to 
conducting the research identified at the sub-component level. The participatory risk assessment and 
management approaches developed  (box 8) are claimed to be new, although they have been developed 
some time ago (as part of the HP Avian Influenza epidemic); some of the techniques and technologies 
proposed in food safety and surveillance techniques seem new. Research component 4 has some 
innovative aspects in objective 4.1.1, while being rather traditional in the other sub-objectives. Sub-
component 4.1 does not exhibit the same outcome focus as other components. Instead, it appears to push a 
concept, rather than considering under what circumstances the AHN sectors should be integrated. Sub-
competent 4.2, on policies, reads better as a stand-alone component, although it also lacked explicit 
mention of extensive interaction with the researchers in the other components, which are crucial for 
success.  
  
4. Quality of research and development partners and partnership management 
 
CRP 4 presents a thorough, pragmatic approach to building and leveraging a partnership network. It 
demonstrates its reliance and commitment to a robust partnership strategy by allocating 47 percent of its 
budget to work with partners.  The principal participating Centers—IFPRI and ILRI, and the Harvest Plus 
Challenge Program have particularly strong track records in building and leveraging effective 
partnerships to advance their work. Although CRP 4 broadens the focus of the CGIAR’s work to include 
health more specifically, and notes as a potential risk, “coordination with the health sector, where the 
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CGIAR has few existing partnerships” (p121), the underlying capacity and experience of the 
collaborating Centers is likely to mitigate this risk.  
 
A high priority task for this program is development of an explicit partnership strategy.  This task will be 
supported by IFPRI’s Partnership Coordinator. ILRI has done extensive work on its own partnership 
strategy and IFPRI has institutionalized partnership management as an element of its management 
structure. A clear typology of partners is articulated early in the proposal and consistently used in the 
descriptions at the component level, namely:  enablers (policy makers and decision makers, including 
donors/investors), development implementers, value chain actors, and research partners (p19).  The 
proposal demonstrates a strong grasp of the value added as well as the strategic importance of enlisting 
and making use of the right mix of partners to advance the research and leverage its adoption across a 
continuum of beneficiaries and actors from the household level to the policy arena.  However, the private 
sector is either ignored, or mentioned as a general category although they will be essential for 
implementation of several outcomes.  In addition, the program seems to be well linked to the regional 
initiatives in Africa, but less so to other regional institutions, such as the Pan-American Health 
Organization, which is not mentioned at all. The proponents recognize the challenges of managing many 
partners and the identification of an individual to take overall responsibility for partnerships, which is 
commended. Because of CRP 4’s breadth of focus, the proposal itself enlists the participation of 10 
CGIAR Centers in addition to the Harvest Plus CP, four of those (Bioversity, CIAT, IFPRI and ILRI) 
with Harvest Plus will contribute $3 million or more to the proposal.  Additionally, linkages to other 
CRPs are listed (Appendix 6, table 1) but are often not easy to interpret. Relationships between livestock 
disease activities have been mentioned. Research on fruits and nutrition is stated to take place through 
CRP 6 but this component (i.e. CRP 6.1) is a very modest part of that proposal. Rather than being 
reassuring, the treatment of linkages with other Centers and CPs raise questions of boundaries and “co-
financing” which remain to be worked out. 
  
As far as a reader can assess, no formal agreements have yet been made with the partners beyond the 
CGIAR Centers although many partners were involved in the IFPRI New Delhi meeting, and the core 
CGIAR partners have been involved in the planning process. The arrangements and responsibilities for 
M&E are proposed to be developed in the first year of program implementation. There is little 
information on the adequacy of the research facilities.  As these facilities would have to come for a large 
part from ARIs, more explicit descriptions of which ARIs are to be involved are needed in research 
component 1 and 4.  The other research components seem to have the appropriate partners and facilities 
identified. 
 
5. Appropriateness and efficiency of Program management 
 
IFPRI is the lead Center for CRP 4, although there is formal acknowledgment of ILRI’s standing in the 
program through its chairmanship of the Planning and Management Committee and a role in the 
recruitment and evaluation of the Program Director.  As the lead Center, IFPRI will provide financial and 
management services to the CRP, provide accountability to the Consortium, and oversee the Program 
Director. The proposed structure for program management and oversight includes: An Independent 
Advisory Committee, a Planning and Management Committee (PMC), the Program Director, a Program 
Research Team, comprising the four research leaders from each of the research components, and a 
Program Management Unit (PMU), which includes a research coordinator, a program manager, and two 
administrative staff. Communications and partnership management are not included in the proposed 
management structure although identified as critical functions throughout the proposal. The structure 
accommodates the relative importance of the two principal participating Centers, and also reflects a useful 
balance between inside and outside perspectives.  Where other CRPs give a cautionary level of attention 
to conflict resolution mechanisms, CRP 4 seems less concerned by the prospect of conflicts among 
partners or over resource allocations to research priorities.  The proposal accepts a recommendation from 
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the Consortium Board to assign ILRI the chairmanship of the Planning and Management Committee for 
two years, and to provide ILRI with a role in the recruitment and evaluation of the Program Director. 
The Program and Management Committee itself comprises both the program’s research leaders, and three 
representatives from participating Centers and implementing partners.  It has a reasonable scope of work 
and authority, meeting face-to-face twice a year or more often as needed.  The Program Director is the 
convener, which provides a subtle affirmation of the Program Director’s relative relationship and 
authority within the structure. 
 
Program Director: The Program Director will be identified and employed by IFPRI, as the lead Center, 
and report directly to the DG.  As noted above, ILRI will play a role in the recruitment and evaluation of 
the Program Director.  The position is given clear responsibility for the overall intellectual leadership and 
management of the CRP, and serves as the external representative of the program with a role in 
partnership development, communications and advocacy, and resource mobilization. 
 
The proposal implies that research leaders will be drawn from among the Centers with existing research 
portfolios that align with the four research components; it is not clear who has the authority to appoint the 
research leaders or to evaluate their performance.  Although there is a common bias within the CRPs to 
have very small management footprints, at some point it will be important to provide the Program 
Director with a more explicit role in recruitment and evaluation of research leaders. 
 
Communications and Partnership Management: The proposal makes a convincing case for the 
importance of effectively identifying and developing partners, and for the central role of a coherent, well 
integrated communications strategy to the success of the program (p113-114).  In analyzing potential 
risks, the proposal notes: “Linking research to implementation (Research Component 4) will require 
extensive investment in communication, dialogue, information sharing, internal education, and advocacy. 
(p122)”.  In both areas, the CRP proposes to identify taskforces to develop strategies for partnerships and 
communications, but it fails to dedicate staff capacity at the program management level to coordinating 
and overseeing these strategies.  Neither function should be fulfilled on an ad hoc basis by borrowing 
existing capacity from IFPRI or other Centers.  The partnership strategy will be complex and involve the 
engagement of new spheres of influence and different actors than have been the traditional scope of the 
Centers.  It would be prudent to include a management position within the Program Management Unit 
that can protect the strategy, help to coordinate and align it implementation, evaluate its effectiveness and 
continue the identification and cultivation of new partners as the program moves forward. Similarly, if, as 
the proposal states, the program “places priority importance on establishing a strong communications 
function from the beginning of the program (p.113),” it must include the capacity to manage this function 
and the underlying strategy as part of the Program Management Unit—which it does not do. 
 
In general, IFPRI as the lead Center has the level of authority that it needs to serve as an effective 
fiduciary. It has not assigned itself a level of control that curtails the influence of participating Centers 
and partners, or that raises serious issues about the potential for conflicts of interest.  Monitoring and 
evaluation functions are considered in the management realm, which may deprive them of the benefit of 
challenging, disinterested assessments.  
  
6. Clear accountability and financial soundness, and efficiency of governance  
 
The budget presentation for the project is straightforward. The total CRP budget over three years is 
projected to be $191 million.  The proposal requests $17 million from the Fund in 2011, rising to $44 
million in 2013.  CRP management is budgeted at 2 percent of the total budget and ranges in value from 
$1.3 to $1.5 over three years.  There is no separate line item for communications.  It is difficult to tell 
from the budget narrative and the detail whether the amount assigned to management resulted from 
estimating the actual costs of management or deciding that 2 percent was as much as should be spent on 
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the management functions.  IFPRI and other Centers are clearly incorporating some management 
functions related to the management of the CRP through the Centers’ existing management structures.  
While this makes sense and is clearly efficient in terms of “backroom” functions like accounting, grants 
management, IT support and personnel, it is not ideal to disaggregate more critical management 
functions, like communications, partnership strategy and coordination, and resource mobilization, wholly 
to various Centers (even the lead Center).  These are critical components of the proposal’s success as 
outlined in the proposal itself; they are legitimate management functions, have clear costs, and should be 
coordinated and managed for results by the Program Director within the CRP’s management unit. 
 
Governance and Oversight: The Independent Advisory Committee will bring together scientists, partner 
representatives and a member of the current advisory committee of Harvest Plus.  Its primary role is to 
advise the management committee and IFPRI DG, although the management committee is required to 
respond formally to its recommendations.  The advisory committee is proposed to meet face-to-face once 
a year.  Its membership may be expanded temporarily to accommodate the program’s need for specific 
expertise or perspectives.   Nominations will be solicited broadly from partners and participating centers, 
with the Planning and Program Management Committee (a relatively well-balanced group) advancing a 
slate of candidates for confirmation by the IFPRI board.  The committee would be strengthened if there 
was a mechanism that enabled the identification of a chair for the group, and if the appointment process 
included a term limit.  It should also meet more than once a year and could meet virtually if there are not 
sufficient resources to support a second face-to-face meeting. 
   
It is difficult to judge the appropriateness of the budget and budget increases when so much of the 
proposal remains to be developed. Currently a very large budget is earmarked for partners/collaborators 
on biofortification. While Harvest Plus and AgroSalud are well described in the proposal, it is not clear to 
what extent the Harvest Plus activities will be generally merged into the program structure and what the 
final balance between biofortification (currently around 50% of the total program) and the other 
components will be. Thus it does not make sense to embark on a rapid deployment of CRP4 in 2011 (as 
suggested on p128), before many of the major potential partners have been adequately consulted to refine 
activities and a more structured and balanced work plan is in place.  For this reason the ISPC has 
recommended that the proposed approach for implementing CRP4 activities be approved, but that 
approval of the content and substance of the program be withheld until a more detailed proposal is 
submitted. 
 
 
